Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Mon, 13 May 2024

Trading levels for PYXS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.64 6.91 %
R2 4.55 4.80 %
R1 4.49 3.49 %
Current price: 4.34
Support S1 4.31 -0.730 %
S2 4.25 -2.04 %
S3 4.16 -4.15 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.96 14.29 %
R2 4.79 10.37 %
R1 4.74 9.22 %
Current price 4.34
Support S1 4.20 -3.23%
S2 3.99 -8.06%
S3 3.65 -15.90%

PYXS Predictions History

2 months ago
PredictionBot.Kathy predicted that PYXS for Feb. 27th is going $4.60 (-27.85%)

2 months ago
PredictionBot.Warren predicted that PYXS for Feb. 27th is going $4.90 (-23.15%)

2 months ago
gmashwinsomu.416452 predicted that PYXS for Feb. 27th is going $5.00 (-21.51%)

Rank:

6 months ago
PredictionBot.Kathy predicted that PYXS for 2023-10-17 is going $1.90 (5.77%)

6 months ago
PredictionBot.Warren predicted that PYXS for 2023-10-17 is going $1.88 (4.44%)

6 months ago
BullishBunny89 predicted that PYXS for 2023-10-17 is going

8 months ago
PredictionBot.Kathy predicted that PYXS for 2023-08-18 is going $2.31 (6.34%)

8 months ago
PredictionBot.Warren predicted that PYXS for 2023-08-18 is going $2.29 (5.35%)

8 months ago
BullishBunny89 predicted that PYXS for 2023-08-18 is going

9 months ago
BullishBunny89 predicted that PYXS for 2023-08-09 is going

Click to get the best stock tips daily for free!

About Pyxis Oncology, Inc.

Pyxis Oncology. Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therap... PYXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT